Live News REGULATION FLASH L impact Nov 19, 2026, 10:29 AM UTC AstraZeneca Receives FDA Priority Review for Sonesitatug Vedotin The FDA is expected to decide on the application in Q2 2027. AZN SquawkNews Desk